ANI PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

05 May 2025 09:52:17 By NetDania Notify

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

05 May 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

02 May 2025 13:34:23 By NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

29 Apr 2025 12:06:34 By NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

28 Apr 2025 09:46:14 By NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

25 Apr 2025 13:49:24 By NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

17 Apr 2025 15:49:11 By NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

16 Apr 2025 11:51:13 By NetDania Notify

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

09 Apr 2025 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

31 Mar 2025 16:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

19 Mar 2025 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

18 Mar 2025 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

14 Mar 2025 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

03 Mar 2025 16:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

28 Feb 2025 06:50:16 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 Feb 2025 16:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 Jan 2025 16:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 Jan 2025 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 Jan 2025 06:50:00 By Nasdaq GlobeNewswire